TY  - JOUR
AU  - Rossignol, Patrick
AU  - Lainscak, Mitja
AU  - Crespo-Leiro, Maria G
AU  - Laroche, Cécile
AU  - Piepoli, Massimo F
AU  - Filippatos, Gerasimos
AU  - Rosano, Giuseppe M C
AU  - Savarese, Gianluigi
AU  - Anker, Stefan D
AU  - Seferovic, Petar M
AU  - Ruschitzka, Frank
AU  - Coats, Andrew J S
AU  - Mebazaa, Alexandre
AU  - McDonagh, Theresa
AU  - Sahuquillo, Ana
AU  - Penco, Maria
AU  - Maggioni, Aldo P
AU  - Lund, Lars H
AU  - Heart Failure Long-Term Registry Investigators Group
PY  - 2020
DO  - 10.1002/ejhf.1793
UR  - https://hdl.handle.net/10668/25920
T2  - European journal of heart failure
AB  - We assessed the interplay between hyperkalaemia (HK) and renin-angiotensin-aldosterone system inhibitor (RAASi) use, dose and discontinuation, and their association with all-cause or cardiovascular death in patients with chronic heart failure (HF). We...
LA  - en
KW  - Heart failure
KW  - Hyperkalaemia
KW  - Hypokalaemia
KW  - Mineralocorticoid receptor antagonists
KW  - Prognosis
KW  - Renin-angiotensin-aldosterone system inhibitors
KW  - Aldosterone
KW  - Angiotensin Receptor Antagonists
KW  - Angiotensin-Converting Enzyme Inhibitors
KW  - Angiotensins
KW  - Heart Failure
KW  - Humans
KW  - Hyperkalemia
KW  - Mineralocorticoid Receptor Antagonists
KW  - Registries
KW  - Renin
TI  - Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry.
TY  - research article
VL  - 22
ER  -